These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1236699

  • 1. [Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].
    Kirsch R.
    Schweiz Rundsch Med Prax; 1975 Nov 04; 64(44):1414-7. PubMed ID: 1236699
    [No Abstract] [Full Text] [Related]

  • 2. [Brain edema in neurosurgery. Trial with an aldosterone-antagonist (soldactone) (author's transl)].
    Anderes JP, de Tribolet N, Zander E.
    Schweiz Rundsch Med Prax; 1977 Aug 09; 66(32):1020-6. PubMed ID: 556440
    [No Abstract] [Full Text] [Related]

  • 3. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
    Coltorti M, Radaeli E, Ciaccio S, Corsini R, Trebbi R.
    Clin Ter; 1976 Feb 15; 76(3):215-34. PubMed ID: 963962
    [No Abstract] [Full Text] [Related]

  • 4. [Potassium canreonate in neurosurgical brain edema].
    Mille T, Rodriguez R, Baena Y.
    Minerva Chir; 1976 Feb 15; 30(13-14):781-9. PubMed ID: 1221307
    [Abstract] [Full Text] [Related]

  • 5. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC, Bräuninger HJ.
    MMW Munch Med Wochenschr; 1975 Sep 15; 117(37):1483-6. PubMed ID: 810673
    [Abstract] [Full Text] [Related]

  • 6. [Aldosterone antagonists in coronary insufficiency].
    Osswald H.
    Med Klin; 1978 Jan 20; 73(3):84-8. PubMed ID: 622061
    [No Abstract] [Full Text] [Related]

  • 7. [Double-blind study on the effects of potassium canrenoate on perifocal edema in acute cerebral ischemia].
    Bidabé AM, Floras P, Orgogozo JM, Péré JM, Dartigues JF, Caillé JM.
    Agressologie; 1982 Jan 20; 23(C):35-41. PubMed ID: 7125090
    [No Abstract] [Full Text] [Related]

  • 8. The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.
    Cristodorescu R, Puschita M, Deutsch G, Berger E, Luca C.
    Med Interne; 1977 Jan 20; 15(1):27-34. PubMed ID: 841250
    [Abstract] [Full Text] [Related]

  • 9. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F, Remonda G, Morachioli N, Pugnani M.
    Ann Osp Maria Vittoria Torino; 1982 Jan 20; 25(1-6):61-70. PubMed ID: 7185311
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of advanced respiratory insufficiency using potassium canreonate (Aldactone). Preliminary report].
    Kerjaschki A.
    Wien Med Wochenschr; 1976 Dec 03; 126(49-50):705-7. PubMed ID: 795170
    [No Abstract] [Full Text] [Related]

  • 11. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M, Vizzini GB.
    Minerva Med; 1986 Jan 28; 77(3-4):87-91. PubMed ID: 3511409
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of K-canrenoate in post-surgical treatment of open heart paediatric surgery (author's transl)].
    Capuani A, Bernabei M, Pasque A, Eufrate S.
    G Ital Cardiol; 1980 Jan 28; 10(9):1148-55. PubMed ID: 7461364
    [Abstract] [Full Text] [Related]

  • 13. [Therapeutic effect of canrenoate potassium (soldactone) in patients after open-heart surgery].
    Matsuda K, Tatsuta N, Konishi Y, Minami K, Nishiwaki N, Yamasato A, Chiba Y, Ishihara H, Murata S, Shiraishi Y, Muraguchi T, Hikasa Y.
    Nihon Geka Hokan; 1982 May 01; 51(3):519-27. PubMed ID: 7138201
    [No Abstract] [Full Text] [Related]

  • 14. The use of diuretics in preventing ascites recurrence.
    Arrigoni A, Andriulli A, Gindro T, Verme G.
    Br J Clin Pract; 1988 Mar 01; 42(3):116-20. PubMed ID: 3207572
    [No Abstract] [Full Text] [Related]

  • 15. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
    Sarti F, Milandri GL, Piemontese A, Macchia S, Simoni S, Dal Monte PR.
    Minerva Dietol Gastroenterol; 1984 Mar 01; 30(3):273-80. PubMed ID: 6504377
    [No Abstract] [Full Text] [Related]

  • 16. [False values of blood digoxin in patients with acute and chronic liver disease. Role of canrenoate potassium and comparison of radioimmunologic and immunoenzymatic methods].
    Nardoni A, di Piazza V, Moretti V, Copetti R, Trinco G, Geatti O.
    Clin Ter; 1988 May 31; 125(4):287-90. PubMed ID: 2974364
    [No Abstract] [Full Text] [Related]

  • 17. Clinical study of potassium canrenoate on raised intracranial pressure.
    Node Y, Nakazawa S.
    Adv Neurol; 1990 May 31; 52():557. PubMed ID: 2396562
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S, Bellati G, Ideo G.
    Minerva Dietol Gastroenterol; 1984 May 31; 30(3):255-61. PubMed ID: 6504374
    [No Abstract] [Full Text] [Related]

  • 19. [Efficacy of canrenoate potassium in hypertensive cardiopathy. Clinical and echocardiographic evaluation].
    Caporicci D, Achilli L.
    Minerva Cardioangiol; 1984 Sep 31; 32(9):581-7. PubMed ID: 6514202
    [No Abstract] [Full Text] [Related]

  • 20. [Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism].
    Tartagni F, Pasetti L, Ambrosioni E, Magnani B.
    G Clin Med; 1979 Mar 31; 60(3):196-206. PubMed ID: 520727
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.